Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma
Jason Miska, Aida Rashidi, Catalina Lee-Chang, Peng Gao, Aurora Lopez‐Rosas, Peng Zhang, Rachel A. Burga, Brandyn Castro, Ting Xiao, Yu Han, David Hou, Samay Sampat, Álex Cordero, Joshua S. Stoolman, Craig Horbinski, Mark R. Burns, Yana K. Reshetnyak, Navdeep S. Chandel, Maciej S. Lesniak
Abstract
T cells. Active de novo synthesis of highly basic polyamines within TAMCs efficiently buffered low intracellular pH to support the survival of these immunosuppressive cells in the harsh acidic environment of solid tumors. Administration of difluoromethylornithine (DFMO), a clinically approved inhibitor of polyamine generation, enhanced animal survival in immunocompetent mice by causing a tumor-specific reduction of polyamines and decreased intracellular pH in TAMCs. DFMO combination with immunotherapy or radiotherapy further enhanced animal survival. These findings indicate that polyamines are used by glioblastoma TAMCs to maintain normal intracellular pH and cell survival and thus promote immunosuppression during tumor evolution.